Gene+
Beijing · Founded 2015
About Gene+
Gene+ operates in the biotechnology industry, focusing on genetic research and development. The company offers a range of services including gene panel development and mutation detection in peripheral blood. Gene+ also provides Next Generation Sequencing (NGS) services, contributing to the field of oncology. Their Smart Laboratory, known as Gene+sLab, is another key aspect of their operations. The company is also involved in tumor gene detection, offering precision medicine series, tumor whole process monitoring, and early tumor screening and diagnosis services.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Estimated revenue: $50K – $100K
- Total funding: $38.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2020)
- Website: https://en.geneplus.cn/
- Phone: 86-400-166-6506
Industries & Categories
Biotechnology, Genetics, Medical
Social Profiles
Canonical: https://fsome.com/organization/gene-157907 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.